Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

2 terminated/withdrawn out of 12 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

4 recruiting3 with results

Enrollment Performance

Analytics

N/A
9(75.0%)
Phase 2
1(8.3%)
Phase 1
1(8.3%)
Phase 3
1(8.3%)
12Total
N/A(9)
Phase 2(1)
Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)